source
- FDA approves Regeneron's Livsayis, first RNAi therapy for generalized myasthenia gravisThe Food and Drug Administration approved Regeneron's Livsayis, an RNA interference drug for generalized myasthenia gravis, marking the company's first marketed RNAi therapy. The drug, originally…
- Sanders says expanded Medicare plan may still pass despite Trump’s potential vetoSenator Bernie Sanders told reporters that he is not certain a Trump veto would block an expanded Medicare for All proposal, suggesting the legislation could still move forward. The proposal appea…